Rad Tech CE, ASRT, ARRT® CE, Category A Credits | Radiology Continuing Education

Approvals/Requirements Satisfied by eRADIMAGING Courses

  • ASRT approval for ARRT Category A credit
  • All Courses eligible of international radiographers' CPD requirements
  • ASRT and MDCB are approved continuing education providers of ARRT and all courses are accepted by ARRT
  • California CE requirements met for all radiography courses
  • NMTCB accepted (All Courses)
  • All Courses available for RRAs
  • ARMRIT accepted (All MRI Courses)
  • MDCB approval by the Medical Dosimetrist Certification (Selected Courses)
  • Florida approval for all courses 1 credit or more
  • ARDMS accepted (All Courses)
  • CAMRT and Sonography Canada recognize the ASRT approval (All Courses)
  • Approval: -
  • Release Date: 6/25/2019
  • Expiration Date: 7/1/2022
  • Credit Hours: 1.25 Credits
  • ACCME Approval: This course is approved by the ACCME. (Release Date: 7/10/2019  Expiration Date: 7/10/2022)
  • Course Description and objectives:

    Course Description
    Rheumatoid arthritis (RA) is a systemic, autoimmune inflammatory disease that causes serious physical impairment over time. Imaging is critical to the early diagnosis of RA and essential to measuring the response to treatment. Although most clinical practices use standard radiography, ultrasound, and, less often, magnetic resonance imaging to detect the hallmark characteristics of RA (eg, synovitis, bony deformities, and joint erosion), positron emission tomography (PET) is emerging as a highly reliable tool to assess at the molecular level the processes of inflammation underlying the disease. Cellular alterations that precede structural changes can be characterized by PET even before symptoms appear. As such, PET has the potential to become the most useful imaging medium for identifying synovitis and predicting future joint destruction. New radio tracers now in development show great promise in targeting specific molecular entities central to inflammatory processes, allowing a more accurate characterization of underlying pathology of disease and a better understanding of potential targets for treatment.

    Learning Objectives
    After reading this article, the participant should be able to:

    • Evaluate the potential for PET imaging in the detection and monitoring of RA activity.
    • Describe the different radiotracers used with PET for imaging of RA, particularly in the assessment of cellular metabolism, cell proliferation, and macrophage infiltration.
    • Compare clinical studies investigating the performance of PET in the early diagnosis and treatment monitoring RA, and its limitations.
    • Appraise the use of hybrid imaging systems in RA, especially PET-MRI.

    Categories: Nuclear Medicine, Computed Tomography, Magnetic Resonance Imaging

  • CE Information:

    CE Information
    In order to receive CE credit, you must first complete the activity content. When completed, go to the “Take CE Test!” link to access the post-test.

    Submit the completed answers to determine if you have passed the post-test assessment. You must answer 8 out of 10 questions correctly to receive the CE credit. You will have no more than 3 attempts to successfully complete the post-test.

    Participants successfully completing the activity content and passing the post-test will receive 1.25 ARRT Category A credits or 1.25 AMA PRA Category 1 Credit(s)™.

    Approved by the American Society of Radiologic Technologists for ARRT Category A credit.

    Approved by the state of Florida for ARRT Category A credit.

    Texas direct credit.

    This activity may be available in multiple formats or from different sponsors. ARRT does not allow CE activities such as Internet courses, home study programs, or directed readings to be repeated for CE credit in the same biennium.

    TARGET AUDIENCE
    This activity is designed to meet the needs of Radiologic Technologists and Physicians, specifically Radiologists.

    This activity is provided by AKH Inc., Advancing Knowledge in Healthcare, for physician credit.

    Release Date: 9/1/2018

    Expiration Date: 9/1/2020

    Physicians
    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare, and eRADIMAGING. AKH Inc., Advancing Knowledge in Healthcare, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for Physicians.

    AKH Inc., Advancing Knowledge in Healthcare, designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Physician Assistants
    NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

    If you have any questions relating to the CME accreditation of this activity, please contact AKH Inc. at jgoldman@akhcme.com.

    COMMERCIAL SUPPORT:
    This activity is NOT supported by a commercial educational grant.

    DISCLOSURE DECLARATION
    It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH prior to accreditation of the activity.

    DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS
    This educational activity does not include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    AKH Inc.’s courses are designed solely to provide healthcare professionals with information to assist in their practice and professional development. The courses are researched thoroughly, utilizing current literature and including practical experiences. AKH’s courses are not to be considered a diagnostic tool to replace professional advice or treatment. The courses serve as a general guide to the healthcare professional, and therefore, they cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH educational courses do not endorse commercial products. The author(s) and the publisher specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the courses. AKH further disclaims any responsibility for undetected errors, or from the reader’s misunderstanding of the course.


Positron Emission Tomography in the Diagnosis and Treatment of Rheumatoid Arthritis

Steven Marks*

*President, MedCom Consultants, Inc, Potomac MD

 

Address correspondence to: Steven Marks, MedCom Consultants Inc, 1311 Fallsmead Way, Potomac MD 20854. Email: steven.marks52@gmail.com

Disclosure statement: Steven Marks reports having no financial or advisory relationship with any corporate, medical, or political organization doing work related to this paper or other business activity at MedCom Consultants, Inc.

AKH Inc. planners and reviewers have no relevant financial relationships to disclose.

 

 

ABSTRACT

Rheumatoid arthritis (RA) is a systemic, autoimmune inflammatory disease that causes serious physical impairment over time. Imaging is critical to the early diagnosis of RA and essential to measuring the response to treatment. Although most clinical practices use standard radiography, ultrasound, and, less often, magnetic resonance imaging to detect the hallmark characteristics of RA (eg, synovitis, bony deformities, and joint erosion), positron emission tomography (PET) is emerging as a highly reliable tool to assess at the molecular level the processes of inflammation underlying the disease. Cellular alterations that precede structural changes can be characterized by PET even before symptoms appear. As such, PET has the potential to become the most useful imaging medium for identifying synovitis and predicting future joint destruction. New radio tracers now in development show great promise in targeting specific molecular entities central to inflammatory processes, allowing a more accurate characterization of underlying pathology of disease and a better understanding of potential targets for treatment.

View the full content

Sample eRADIMAGING Course *

* This sample course is for reference purposes only. It is not currently available for earning CE credits. To earn ARRT CE credits please subscribe to eRADIMAGING where you will see a complete listing of all active and eligible CE courses.

Become a member

Satisfy your CE requirements today!

Join now

We offer special group rates, call or email.

908-253-9001

webmaster@eradimaging.com

Newsletter

Enter your email address to receive our new course alerts.